Orally-active mavacamten – which was acquired by BMS when it bought MyoKardia for $13 billion in 2020 – will launch under the Camzyos brand name with a list price of $89,500 per year.
Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab – was unable to improve on Opdivo alone in the RELATIVITY-098 ...
Many electric distribution organizations are presently evaluating their approach to integrating three key operational systems – SCADA (Supervisory Control and Data Acquisition), OMS (Outage Management ...
This project aims to develop a SCADA system using Node-RED for monitoring and controlling a Modular Production System (MPS). The project includes integration of multiple PLCs using FINS UDP and Modbus ...
After hours: March 12 at 7:51:23 PM EDT Loading Chart for BMY ...
Mar. 11, 2025 — A new study presents a compelling new model for the formation of super-Earths and mini-Neptunes -- planets that are 1 to 4 times the size of Earth and among the most common in ...
A world class department for management education and research in the centre of London. This is Management at LSE. Not business as usual.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results